Divalproex Sodium
Product Images NDC 53808-1080

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 53808-1080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 500mg (Divalproxex 500mg)

Label for Divalproex Sodium 500 mg delayed-release tablets, quantity of 30, labeled for prescription use only. The label includes lot number, expiration date, and indicates packaging by DOH Central Pharmacy, Tallahassee, FL 32304. A UPC barcode is also present.*

FDA Label Image

Structure (Divalproextablets Figure 01)

Chemical structure of divalproex sodium, showing the polymeric form with sodium ion and carboxylate groups, representing its active ingredient molecular configuration.*

FDA Label Image

Comparison Of Percentage Of Patient Separated By Study (Divalproextablets Figure 02)

A bar chart comparing percentages between placebo (PBO) and Divalproex Sodium (DVPX) groups for two studies labeled Study 1 (YMRS) and Study 2 (MRS). Study 1 shows 26% for PBO and 60% for DVPX, while Study 2 shows 29% for PBO and 58% for DVPX.*

FDA Label Image

% Reduction In Cps Rate Vs % Of Patients (Divalproextablets Figure 03)

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium and placebo across the percentage of patients. The vertical axis shows the change in CPS rate from worsening to improvement, while the horizontal axis represents the percentage of patients. The Divalproex Sodium group is represented by a solid line, showing greater improvement relative to the placebo group, which is shown with a dotted line.*

FDA Label Image

% Reduction In Cps Rate Vs % Of Patients (Divalproextablets Figure 04)

A line graph showing the percent reduction in complex partial seizures (CPS) rate among patients treated with high and low doses of Divalproex Sodium. The x-axis represents the percentage of patients, and the y-axis represents the percent reduction in CPS rate, with indicators for improvement, no change, and worsening. Two lines compare high dose (solid) and low dose (dashed) effects.*

FDA Label Image

Mean 4-week Migraine Rates (Divalproextablets Figure 05)

A bar chart comparing placebo and Divalproex Sodium in two separate studies labeled Study 1 and Study 2. The y-axis appears to measure an unspecified variable in numeric scale, with the placebo bars higher than the Divalproex Sodium bars in both studies, indicating a comparative analysis between these groups.*

FDA Label Image

Company Logo (Divalproextablets Figure 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.